AFP and hepatocellular carcinoma: Current American Association for the Study of Liver Disease (AASLD) recommendations on surveillance of HCC are for ultrasound (US) imaging, with or without serum Alpha-fetoprotein (AFP) measurement for only the highest risk patients [2].